UNSPSC 51191967: L-ornitin/ L-aspartate

L-ornithine-L-aspartate (LOLA) is a salt of two nonessential L-amino acids: ornithine and aspartic acid. It is used as a medicinal product to lower blood ammonia concentration and to eliminate symptoms of hepatic encephalopathy associated with liver cirrhosis.

UNSPSC 51191967 L-ornithine/L-aspartate, a Commodity code, does not align with the recent state and local contract opportunities posted under this classification. The code nominally describes amino acid pharmaceutical compounds, yet the recent opportunities posted under it span emergency medical services software (drug-dosage calculation applications), long-term care pharmacy distribution, pharmacy benefits network qualifications, naloxone distribution, forensic drug reference standards, and general procurement conference advertising—none of which involve L-ornithine/L-aspartate procurement or supply. The mismatch suggests either miscoding of opportunities at the point of posting or upstream classification drift in the state and local procurement systems. No concrete recent activity supports purchase volume, pricing structure, or typical supplier engagement patterns for this specific amino acid compound at the state or local level.

Given the absence of relevant recent opportunities, this code shows little actionable procurement signal for vendors seeking to pursue L-ornithine/L-aspartate sales to state and local governments. The opportunities tagged under it reflect broader pharmaceutical, medical supply, and forensic laboratory procurement—categories that do not intersect with amino acid supplementation or therapeutic compound distribution. Business development professionals should verify code assignment with issuing bodies before allocating pursuit resources to this classification.